Arcus Biosciences
RCUS
RCUS
186 hedge funds and large institutions have $763M invested in Arcus Biosciences in 2025 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 98 increasing their positions, 29 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
186
Holders Change
+1
Holders Change %
+0.54%
% of All Funds
2.53%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
33
Increased
98
Reduced
29
Closed
31
Calls
$1.09M
Puts
$1.03M
Net Calls
+$54K
Net Calls Change
-$2.95M
Top Buyers
| 1 |
SCM
1
Suvretta Capital Management
New York
|
$20.1M |
| 2 |
WP
2
Woodline Partners
San Francisco,
California
|
$40.2M |
| 3 |
GS
3
Gilead Sciences
Foster City,
California
|
$247M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$52.5M |
| 5 |
5
BlackRock
New York
|
$85.3M |
